These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7662605)

  • 21. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
    Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
    Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty.
    Hokimoto S; Ogawa H; Saito T; Oshima S; Noda K; Soejima H; Takazoe K; Date H; Ishibashi F; Nakamura S; Yasue H
    Jpn Circ J; 2000 Nov; 64(11):831-4. PubMed ID: 11110426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty.
    Schumacher M; Tiran A; Eber B; Toplak H; Wilders-Truschnig M; Klein W
    Am J Cardiol; 1992 Feb; 69(5):572. PubMed ID: 1531283
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased neopterin in patients with chronic and acute coronary syndromes.
    Schumacher M; Halwachs G; Tatzber F; Fruhwald FM; Zweiker R; Watzinger N; Eber B; Wilders-Truschnig M; Esterbauer H; Klein W
    J Am Coll Cardiol; 1997 Sep; 30(3):703-7. PubMed ID: 9283529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Restenosis after percutaneous transluminal coronary angioplasty].
    Haze K
    Kokyu To Junkan; 1989 Dec; 37(12):1283-93. PubMed ID: 2616905
    [No Abstract]   [Full Text] [Related]  

  • 28. Percutaneous transluminal coronary angioplasty in silent ischemia.
    Tuzcu EM; Nisanci Y; Simpfendorfer C; Dorosti K; Franco I; Hollman J; Whitlow P
    Am Heart J; 1990 Apr; 119(4):797-801. PubMed ID: 2321501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
    Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise echocardiography performed early and late after percutaneous transluminal coronary angioplasty for prediction of restenosis.
    Hoffmann R; Lethen H; Flachskampf FA; Hanrath P
    Eur Heart J; 1995 Dec; 16(12):1872-9. PubMed ID: 8682020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restenosis following coronary angioplasty.
    Fanelli C; Aronoff R
    Am Heart J; 1990 Feb; 119(2 Pt 1):357-68. PubMed ID: 2405612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease.
    Miyata M; Biro S; Arima S; Hamasaki S; Kaieda H; Nakao S; Kawataki M; Nomoto K; Tanaka H
    Am Heart J; 1996 Aug; 132(2 Pt 1):269-73. PubMed ID: 8701886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.
    Johansson SR; Wiklund O; Karlsson T; Hjalmarson A; Emanuelsson H
    Eur Heart J; 1991 Sep; 12(9):1020-8. PubMed ID: 1936002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary artery aneurysm formation following percutaneous transluminal coronary angioplasty: treatment of associated restenosis with repeat percutaneous transluminal coronary angioplasty.
    Walford GD; Midei MG; Aversano TR; Gottlieb SO; Chew PH; Brinker JA
    Cathet Cardiovasc Diagn; 1990 Jun; 20(2):77-83. PubMed ID: 2354519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transluminal extraction atherectomy and adjunctive balloon angioplasty for restenosis after Palmaz-Schatz coronary stent implantation.
    Ikari Y; Yamaguchi T; Tamura T; Isshiki T; Saeki F; Hara K
    Cathet Cardiovasc Diagn; 1993 Oct; 30(2):127-30. PubMed ID: 8221864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical prognosis of moderate restenosis after percutaneous transluminal coronary angioplasty].
    Fukuzawa S; Ozawa S; Katagiri M; Watanabe H
    J Cardiol; 1995 Feb; 25(2):63-8. PubMed ID: 7897608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans.
    Condado JA; Waksman R; Gurdiel O; Espinosa R; Gonzalez J; Burger B; Villoria G; Acquatella H; Crocker IR; Seung KB; Liprie SF
    Circulation; 1997 Aug; 96(3):727-32. PubMed ID: 9264475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.